Respiratory failure is one of the most uncommon and serious adverse drug reactions. Low-molecular-weight-dextran (Dextran-40) is a useful adjunctive anti-platelet agent in the setting of coronary angioplasty and intracoronary stent placement. We report the occurrence of the adult respiratory distress syndrome following intravenous infusion of Dextran-40.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ccd.1810320310 | DOI Listing |
Publication Analysis
Top Keywords
adult respiratory
8
respiratory distress
8
distress syndrome
8
intravenous infusion
8
syndrome complicating
4
complicating intravenous
4
infusion low-molecular
4
low-molecular weight
4
weight dextran
4
dextran respiratory
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!